Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2013
05/01/2013CN101671689B Recombinant expression carrier containing schistosoma japonicum gene and application thereof
05/01/2013CN101633932B Preparation method and application of high-density molecular simulation epitope peptide of ochratoxin A
05/01/2013CN101535340B Erythropoietin compositions
05/01/2013CN101487020B Preparation and use of recombinant gold needle mushroom immunomodulatory protein
05/01/2013CN101094688B Multimeric constructs
04/2013
04/30/2013US8431770 Method of producing sialytransferase-modified proteins
04/30/2013US8431769 Non-aggregating fluorescent proteins and methods for using the same
04/30/2013US8431688 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis
04/30/2013US8431382 Chloramphenicol resistance selection in Bacillus licheniformis
04/30/2013US8431381 ATP:citrate lyase genes
04/30/2013US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
04/30/2013US8431365 β1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
04/30/2013US8431364 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
04/30/2013US8431363 Polynucleotides encoding therapeutic inhibitors of PAI-1
04/30/2013US8431362 Polypeptides having xylanase activity and polynucleotides encoding same
04/30/2013US8431361 Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant Clostridium difficile toxin B
04/30/2013US8431360 Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels
04/30/2013US8431359 Nucleotide sequences coding tissue factor pathway inhibitor for use in treatment and prevention of blood disorders
04/30/2013US8431350 Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
04/30/2013US8431130 IL-18 binding proteins
04/30/2013US8431129 Method of treating fibroproliferative disorders of the heart and lung
04/30/2013US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)
04/30/2013CA2687542C Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
04/30/2013CA2503125C Novel composition and methods for the treatment of immune related diseases
04/30/2013CA2475235C Production process of recombinant placental growth factor
04/30/2013CA2458995C Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
04/30/2013CA2435664C Ncc2705-the genome of a bifidobacterium
04/25/2013WO2013059740A1 Novel alk and ntrk1 fusion molecules and uses thereof
04/25/2013WO2013059159A1 In vivo method for generating diversity in a protein scaffold
04/25/2013WO2013058516A1 Recombinant vector, recombinant yeast containing the vector, and mass-producing method of glucose oxidase using the yeast
04/25/2013WO2013058388A1 Anti-gap43 antibody
04/25/2013WO2013056645A1 Method for preparing absorbable medical aesthetic product
04/25/2013WO2013033456A3 Microbial nanowires and methods of making and using
04/25/2013WO2012122025A3 Vectors conditionally expressing protein
04/25/2013US20130102482 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
04/25/2013US20130102034 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
04/25/2013US20130102033 Production method of extracellular polysaccharopeptides by trametes versicolor lh1 immobilization using liquid-surface complex carriers in submerged fermentation
04/25/2013US20130102031 Use of somatic hypermutation to create insertion and deletion mutations in vitro
04/25/2013US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity
04/24/2013EP2584043A2 Anti-glypican 3 antibody having improved kinetics in plasma
04/24/2013EP2584037A1 Method for constructing recombinant bacterium for producing non-native protein, and utilization of same
04/24/2013EP2583981A2 Antibodies and related molecules that bind to PSCA proteins
04/24/2013EP2582835A1 Use of psychrophilic anaerobic digestion in sequencing batch reactor for degradation of prions
04/24/2013CN103069000A Eggshell membrane solubilization method using enzymes
04/24/2013CN103068999A Method for inactivating proteases by ph change in a liquid obtained from a cell culture
04/24/2013CN103068369A Method for producing a lipid particle, the lipid particle itself and its use
04/24/2013CN103060415A Preparation method of collagen for treating rheumatic arthritis
04/24/2013CN103060414A Method for preparing fish skin collagen oligopeptides by biological enzyme method
04/24/2013CN103060413A Method for preparing collagen oligopeptide through mixed enzyme
04/24/2013CN103060412A Preparation method of collagen for keeping skin elasticity
04/24/2013CN103060411A Production method of methanol protein peptide
04/24/2013CN103060410A Method for extracting biological active peptide from sea aquatic product
04/24/2013CN103060409A Method for extracting active collagen from sea cucumber
04/24/2013CN103060408A Method for preparing purple perilla oligopeptide with high F value through immobilization enzymatic preparation
04/24/2013CN103060407A Preparation technology of high-transparency squid skin collagen
04/24/2013CN103060406A Method for extracting low molecular weight collagen from cattle bone
04/24/2013CN103060405A Fermentation technique of A40926
04/24/2013CN103060249A Escherichia coli and method for efficiently secreting and expressing human epidermal growth factor by using same
04/24/2013CN103060210A Polymorphic hansenula polymorpha mutant strain and application of polymorphic hansenula polymorpha mutant strain in glutathione biosynthesis
04/24/2013CN103059140A Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in treatment of allergies
04/24/2013CN103059124A Recombined porcine interferon Gamma, coding gene thereof and expressing method
04/24/2013CN103059123A Recombinant porcine interferon beta1, encoding gene and expression method thereof
04/24/2013CN103059122A Recombined porcine interferon alpha 1, as well as gene encoding gene and expression method thereof
04/24/2013CN103059118A Polypeptides comprising an ice-binding activity
04/24/2013CN103059117A High throughput screening of important schistosoma japonicum antigens and application of antigens in schistosomiasis diagnosis
04/24/2013CN103059110A Candida albicans apoptosis-promoting factor gene and application thereof
04/24/2013CN103059104A Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
04/24/2013CN102329846B Pollution-free production method for producing soybean and silkworm chrysalis composite oligopeptides by adopting composite enzyme hydrolysis method
04/24/2013CN102188332B Cosmetic containing oceanic shellfish active peptide and preparation method and application thereof
04/24/2013CN102154422B Method for extracting functional small peptides from low-value sea fish
04/24/2013CN102146426B Method for producing recombinant human-like collagen by expression by Pichia pastoris
04/24/2013CN102030773B Technique for coproducing phytic acid and oligopeptide from defatted rice bran
04/24/2013CN101906438B Method for expressing and producing recombinant human blood coagulation factors VII in animal cells
04/24/2013CN101809151B Method for cellulase production
04/24/2013CN101679965B Endoglucanase ppce and cellulase preparation containing the same
04/24/2013CN101643789B RNA interference mediating small RNA molecules
04/24/2013CN101300346B Novel biological substance nesfatin and its related substances and uses thereof
04/24/2013CN101124331B Site-directed modification of FVIII
04/23/2013US8426573 Nucleic acids encoding TNFγ
04/23/2013US8426572 Artificial entropic bristle domain sequences and their use in recombinant protein production
04/23/2013US8426571 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
04/23/2013US8426565 Dendritic cell marker and uses thereof
04/23/2013US8426556 Method of producing FR901228
04/23/2013US8426185 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods
04/23/2013US8426184 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose
04/23/2013US8426182 Alpha-amylase
04/23/2013US8426180 Use of carbamoyl phosphate synthetase 1 (CPS) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases
04/23/2013US8426178 Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
04/23/2013US8426171 Microorganism producing L-methionine precursor and method of producing L-methionine and organic acid from the L-methionine precursor
04/23/2013US8426168 Process for the preparation of recombinant polypeptides
04/23/2013US8426167 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides
04/23/2013US8426164 Fungal transcriptional activator useful in methods for producing polypeptides
04/23/2013US8426163 Production of lipidated proteins in E. coli
04/23/2013US8426144 Monocyte-derived nucleic acids and related compositions and methods
04/23/2013US8426141 Methods for increasing the therapeutic efficacy of immunoglobulin G class 3 (IgG3) antibodies
04/23/2013US8426124 Providing a host cell that has been infected by a virus and cultivating the host cell at two different temperatures to obtain high titer and improved purity; culturing
04/23/2013US8425912 Immunoconjugates with an intracellularly-cleavable linkage
04/23/2013US8425908 Treatment with anti-ErbB2 antibodies
04/23/2013US8425895 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); treating cancer responsive to interferon alpha therapy
04/23/2013CA2635923C Protein hydrolysates and method of making
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 1125